| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | SB 216763 | GDSC1000 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | pluripotin | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | BRD-K66532283 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | OSI-027 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.013 | 0.6 |
| mRNA | BRD-K41597374 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | AT-7519 | GDSC1000 | pan-cancer | AAC | 0.014 | 0.6 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |